Skip to main content
. Author manuscript; available in PMC: 2018 Aug 21.
Published in final edited form as: Leukemia. 2018 Feb 21;32(6):1421–1426. doi: 10.1038/s41375-018-0063-7

Table 2.

Hematologic and Organ response with treatment in patients with newly diagnosed AL

CPCs Present
N=60
N (%)
CPCs Absent
N=89
N (%)
P value
Hematologic Response
Evaluable N=36 N=67
 Complete Response 12 (33) 26 (39)
 VGPR 11 (31) 18 (27)
 Partial Response 8 (22) 15 (22)
 No response/progression 5 (14) 8 (12)
VGPR or better rate 23 (64) 44 (65) 0.9*
Not evaluable 9 16
Not known/died before assessment 15 6
Organ Response
Cardiac response, n/N (%) 9/19 (47) 20/35 (57) 0.5
Renal response, n/N (%) 20/25 (80) 35/48 (73) 0.5
Liver response, n/N (%) 4/4 (100) 1/7 (14) 0.002
Median time to cardiac response, months (IQR) 9 (4-17) 9 (5-13) 1
Median time to renal response, months (IQR) 7 (3-14) 6 (3-12) 0.8
Median time to liver response, months (IQR) 4 (3-8) 4 (4-4) 1
*

p value for comparison of VGPR or better response

Abbreviations: VGPR: very good partial response; IQR: interquartile range